AN INVESTOR returning to Scotland from America has hailed the “beginning of the end” of the venture capital (VC) “gap” for Scottish life sciences companies after launching his £50 million fund.
Sinclair Dunlop – who has a track record of securing investments from Europe, the Far East and the United States – has opened his Rock Spring Ventures office in Edinburgh and will pump funds into firms throughout the UK.
About half of the cash – which has been raised from the European Investment Fund, Scottish Enterprise, the Strathclyde Pension Fund and Aberdeen, Edinburgh and Glasgow universities – will remain in Scotland.
To read the full, original article click on this link: ‘Beginning of end’ for biotech’s venture capital gap - Management - Scotsman.com
